Clinical Gastroenterology and Hepatology

Papers
(The H4-Index of Clinical Gastroenterology and Hepatology is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Reply442
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?334
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details271
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!239
Reply231
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion218
Editorial Board178
Attribution of Colonoscopy Risk Does Not FIT!174
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis169
Table of Contents167
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward165
Issue Highlights164
Elsewhere in the AGA Journals158
Correction153
FODMAPs in IBS: Revisiting Restriction149
Blue Notes148
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?146
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome142
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study130
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials126
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease125
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis124
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study121
Front Cover118
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial116
Editorial Board116
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission116
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial109
Hepatic Artery Pseudoaneurysm After Whipple Procedure109
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?108
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI108
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy107
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1103
Reply102
Assessment and Significance of Histologic Activity in Crohn’s Disease101
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants101
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia99
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study97
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability96
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction95
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions93
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion93
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels92
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study92
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease91
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?89
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis89
Editorial Board89
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study88
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy88
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy87
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis86
Update in the Treatment of the Complications of Cirrhosis86
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA85
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary85
Reply84
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease84
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease84
Elsewhere in the AGA Journals84
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial81
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis81
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study80
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis75
Effect of five dietary emulsifiers on inflammation, permeability, and the gut microbiome: a placebo-controlled randomized trial.74
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis73
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum73
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease73
Perianal Disease in Pediatric-onset Crohn’s Disease: Incidence, Disease Course, and Long-term Outcomes72
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent72
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling72
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review72
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort71
0.42914009094238